FDA
-
-
-
-
-
-
-
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
-
-
-
-
-
-
-
Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations
-
-
-
-
-
-
-
CELL WORLD - Aiming at Internationalization, Starting from Regulation - The 1st Global Cell Therapy Summit and Hillgene Biopharma Anniversary Celebration Successfully Held
-
-
-
-
-
-
-
Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman
-
-
-
-
-
-
-
Legend Biotech Shares Updated Data from Comprehensive Cilta-Cel Clinical Development Program at ASH 2022
-
-
-
-
-
-
-
Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma
-
-
-
-
-
-
-
Legend Biotech to Highlight Continued Progress in the Treatment of Multiple Myeloma With Updated Data From BCMA CAR-T Studies at 2022 ASCO and EHA
-
251,403 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All